Stem cell innovation system in India: Emerging scenario and future challenges

The present paper is an attempt to explore the emerging stem cell innovation system in India. It is contended that the social capital in terms of linkages of various sorts can no longer be ignored to strengthen the innovation system and that the coevolution of technology and institutions is yet to emerge. It seems that given the nature of complex technologies involved, there is a greater need felt for R&D and training collaboration and hence linkages of various types are taking place. For shaping futures for a balanced growth of this sector, the institutions in India will have to be geared towards greater coordination, promotion of greater knowledge flows at national as well international levels. This paper also analyses the strengths and barriers in the development of rapidly growing stem cell research in India along with future challenges.

[1]  Stem cell science in India: emerging economies and the politics of globalization. , 2007, Regenerative medicine.

[2]  V. Sangwan,et al.  Interview: Affordability at the cutting edge: stem cell therapy for ocular surface reconstruction. , 2010, Regenerative medicine.

[3]  C. Chakraborty,et al.  India’s stem cell research and development perspectives , 2009, International journal of hematology.

[4]  J. Fagerberg.  Innovation: A Guide to the Literature , 2003 .

[5]  Chris Mason,et al.  Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. , 2010, Regenerative medicine.

[6]  Kamini A. Rao,et al.  Derivation and characterization of two sibling human embryonic stem cell lines from discarded grade III embryos. , 2009, Stem cells and development.

[7]  Michael J Lysaght,et al.  Private sector development of stem cell technology and therapeutic cloning. , 2003, Tissue engineering.

[8]  J. Fagerberg,et al.  The Oxford handbook of innovation , 2006 .

[9]  Franco Malerba.  Sectoral systems of innovation: how and why innovation differs across sectors , 2005 .

[10]  P. Desai.  Globalization of Innovations: Changing Nature of India’s Science and Technology Cooperation Policy , 2009 .

[11]  N. Brown,et al.  Commercial development of stem cell technology: lessons from the past, strategies for the future. , 2006, Regenerative medicine.

[12]  Cultivating regenerative medicine innovation in China. , 2010, Regenerative medicine.

[13]  Stephen Colagiuri,et al.  Grand challenges in chronic non-communicable diseases , 2007, Nature.

[14]  Cynthia B. Cohen,et al.  International Stem Cell Tourism and the Need for Effective Regulation: Part I: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype? , 2010, Kennedy Institute of Ethics journal.

[15]  Bela Shah,et al.  Responding to the threat of chronic diseases in India , 2005, The Lancet.

[16]  Abdallah S. Daar,et al.  Regenerative medicine: New opportunities for developing countries , 2006 .

[17]  I. Schwab,et al.  Inherent risks associated with manufacture of bioengineered ocular surface tissue. , 2006, Archives of ophthalmology.

[18]  Franco Malerba,et al.  Sectoral Systems: How and Why Innovation Differs across Sectors , 2006 .

[19]  D. Sipp.  Stem cell stratagems in alternative medicine. , 2011, Regenerative medicine.

[20]  C. Freeman.  The ‘National System of Innovation’ in historical perspective , 1995 .